These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7635695)

  • 1. Long-term prevention of recurrent hepatitis B virus after liver transplantation.
    Ilan Y; Eid A; Tur-Kaspa R
    Isr J Med Sci; 1995 Aug; 31(8):469-73. PubMed ID: 7635695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation in European patients with the hepatitis B surface antigen.
    Samuel D; Muller R; Alexander G; Fassati L; Ducot B; Benhamou JP; Bismuth H
    N Engl J Med; 1993 Dec; 329(25):1842-7. PubMed ID: 8247035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrence of virus B hepatitis after liver transplantation].
    Gugenheim J; Crafa F; Fabiani P; Militerno G; Goubaux B; Saint-Paul MC; Ouzan D; Mouiel J
    Gastroenterol Clin Biol; 1992; 16(5):430-3. PubMed ID: 1326456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin.
    Terrault NA; Zhou S; Combs C; Hahn JA; Lake JR; Roberts JP; Ascher NL; Wright TL
    Hepatology; 1996 Dec; 24(6):1327-33. PubMed ID: 8938155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of viral recurrence following liver transplantation for post-hepatitis B and B-delta cirrhosis].
    Mentha G; Giostra E; Perrin L; Widmann JJ; Stelling MJ; Easton J; Morel P; Huber O; Le Coultre C; Bühler L
    Schweiz Med Wochenschr; 1994 Apr; 124(15):637-41. PubMed ID: 8191267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation.
    Adler R; Safadi R; Caraco Y; Rowe M; Etzioni A; Ashur Y; Shouval D
    Hepatology; 1999 Apr; 29(4):1299-305. PubMed ID: 10094978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
    Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
    Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Lu MQ; Cai CJ; Zhao H; Yang Y; Chen GH
    Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):742-4. PubMed ID: 16836920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retransplantation of the liver for recurrent hepatitis B virus infection: the Paul Brousse experience.
    Roche B; Samuel D; Feray C; Majno P; Gigou M; Reynes M; Bismuth H
    Liver Transpl Surg; 1999 May; 5(3):166-74. PubMed ID: 10226106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E in the treatment of recurrent hepatitis B infection after orthotopic liver transplantation.
    Flowers M; Sherker A; Sinclair SB; Greig PD; Cameron R; Phillips MJ; Blendis L; Chung SW; Levy GA
    Transplantation; 1994 Jul; 58(2):183-92. PubMed ID: 8042236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
    Rosenau J; Kreutz T; Kujawa M; Bahr MJ; Rifai K; Hooman N; Finger A; Michel G; Nashan B; Kuse ER; Klempnauer J; Tillmann HL; Manns MP
    J Hepatol; 2007 Apr; 46(4):635-44. PubMed ID: 17316869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Liu J; Wu GC; Zhang ZT; Wu P; Zhang D; Sun MC; Gao DC; Wang Y; Jia JD; Wang BE
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):976-9. PubMed ID: 16194352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
    Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
    J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY; Cho SH; Lee SM; Koh MB; Noh CH; Kim CW; Choi JY; Yang JM; Han JY; Lee YS
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of antibody to hepatitis B surface antigen after liver transplantation for chronic hepatitis B.
    Lo CM; Fung JT; Lau GK; Liu CL; Cheung ST; Lai CL; Fan ST; Wong J
    Hepatology; 2003 Jan; 37(1):36-43. PubMed ID: 12500186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.